Other Species / Isoforms
  FANCG (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S7-p
_MSRQTTsVGSSCLD
Upstream
Downstream
2 1
Effects on Modified Protein
  • molecular association, regulation
Regulatory protein:
  • ATR (human)
Treatment
  • mitomycin_C
  • wortmannin
FANCG (human) _MSRQTTsVGSSCLD S7-p
FANCG (mouse) QVIPALPKTFSSSLD K11
K28-ub
DRLVRQAkVAQNSGL
0 1
FANCG (human) DRLVRQAkVAQNSGL K28-ub
FANCG (mouse) DQLVRQAKQLtRDSR K32
A30
LVRQAkVAQNSGLTL
0 1
FANCG (human) LVRQAkVAQNSGLTL A30
FANCG (mouse) VRQAKQLtRDSRPsL T35-p
T36
VAQNSGLTLRRQQLA
0 1
FANCG (human) VAQNSGLTLRRQQLA T36
FANCG (mouse) LtRDSRPsLRRQQSA S41-p
L114
QEQQGPRLEQGLREL
0 1
FANCG (human) QEQQGPRLEQGLREL L114
FANCG (mouse) QHHLEPKsQQGLKEL S119-p
K182-ub
KDLLLLLkTWSPPAE
1 0
FANCG (human) KDLLLLLkTWSPPAE K182-ub
FANCG (mouse) EDLLLLLKSWSPPAE K187
K258-ub
ALGSCHRkMGNPQRA
1 0
FANCG (human) ALGSCHRkMGNPQRA K258-ub
FANCG (mouse) ALGACLRKMGNPQRA K263
K347-ub
CGTQSQTkHILASRC
1 0
FANCG (human) CGTQSQTkHILASRC K347-ub
FANCG (mouse) CGTQSQAKHLLASRC K352
S383-p
DSSEPRFsPPPsPPG
Downstream
2 0
Effects on Modified Protein
  • activity, induced
FANCG (human) DSSEPRFsPPPsPPG S383-p
FANCG (mouse) GGSETRFSPPTSSLG S388
S387-p
PRFsPPPsPPGPCMP
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • CDK1 (human)
FANCG (human) PRFsPPPsPPGPCMP S387-p
FANCG (mouse) TRFSPPTSSLGPCIP S392
K430-ub
RTSSLLPkMSRLWED
0 1
FANCG (human) RTSSLLPkMSRLWED K430-ub
FANCG (mouse) RTSSLLPKMSSLWEN K435
K491-ub
FRATPEEkEQGAAFN
0 2
FANCG (human) FRATPEEkEQGAAFN K491-ub
FANCG (mouse) FRTLPEDKEQGSDCE K496
K504-ub
FNCEQGCkSDAALQQ
0 2
FANCG (human) FNCEQGCkSDAALQQ K504-ub
FANCG (mouse) SDCEQKCRSDVALKQ R507
T557-p
TYFHLLQtLkRLDRR
0 1
FANCG (human) TYFHLLQtLkRLDRR T557-p
FANCG (mouse) GSFYLLQTLKRLDRK T560
K559-ub
FHLLQtLkRLDRRDE
Upstream
0 3
Treatment
  • MG132
FANCG (human) FHLLQtLkRLDRRDE K559-ub
FANCG (mouse) FYLLQTLKRLDRKNE K562
K618-ub
EFRTSLPkSCDL___
0 2
FANCG (human) EFRTSLPkSCDL___ K618-ub
FANCG (mouse) EFGTSVLESCVL___ E619